Improving Referral Efficiency and Care Coordination for CAR T-Cell Therapy in Multiple Myeloma

This segment outlines practical strategies to streamline referrals for CAR T-cell therapy in multiple myeloma, addressing common challenges faced by community clinicians such as appointment availability, manufacturing timelines, and treatment capacity. Dr. Raje emphasizes that early education for referring physicians is essential, since many still view CAR T as a late line option and delay referral unnecessarily. Clear, proactive communication channels between community practices and academic centers can reduce uncertainty and accelerate evaluation. Dedicated intake teams, nurse navigators, and social workers help coordinate scheduling, insurance authorization, and logistical planning so that consults and apheresis can occur more efficiently. Dr. Raje notes that expanding networks between myeloma centers and community oncologists has improved referral predictability, and future models aim to bring point of care manufacturing closer to patients. Consistent messaging about updated indications, earlier referral triggers, and streamlined scheduling processes can significantly reduce drop off and allow patients timely access to CAR T-cell therapy.